The Elisa Reader/Microplate Reader is a vital medical device for hospitals, facilitating precise diagnostics and research. This sophisticated equipment efficiently reads microplate assays, delivering accurate results for a wide range of tests. With its user-friendly interface and versatile software, it enables seamless data analysis. Its optical system ensures high sensitivity and a broad detection range, making it ideal for various assays. The compact design saves valuable lab space, while the robust construction ensures longevity. This indispensable tool is crucial for diagnosing diseases, monitoring treatment efficacy, and advancing medical research, making it an indispensable asset for any hospital's laboratory.
The Biological Safety Cabinet is a critical medical equipment for hospitals, ensuring a safe environment for handling hazardous materials. It offers a high level of protection for both operators and the surroundings during the manipulation of infectious agents, chemicals, or pharmaceuticals. This cabinet features HEPA filtration, maintaining a sterile airflow to prevent contamination. Its ergonomic design and advanced airflow controls enhance user comfort and precision. Equipped with a clear viewing window and an alarm system, it guarantees safety and compliance. This indispensable equipment is vital for infection control, research, and pharmaceutical work, making it an essential asset in any hospital's safety protocols.
The BOD (Biochemical Oxygen Demand) Incubator is a crucial medical equipment used in hospitals for environmental and medical research. This specialized incubator maintains a stable temperature, typically 20�°C, 27�°C, or 37�°C, providing an ideal environment for biological sample incubation and testing. It features precise digital controls and uniform temperature distribution to ensure accurate and reproducible results. The interior is spacious, accommodating various sample sizes and containers. With energy-efficient design and robust construction, it's reliable for long-term operation. Hospitals rely on BOD incubators for critical applications, including wastewater analysis, microbiological studies, and medical research, ensuring the highest standards of accuracy and consistency.
The Vertical Autoclave is an indispensable medical equipment used in hospitals for sterilization of surgical instruments, laboratory glassware, and medical waste. With its vertical chamber design, it maximizes space efficiency while ensuring thorough sterilization. This autoclave operates with steam under pressure, effectively eradicating harmful microorganisms. It boasts precise digital controls and safety features, such as automatic pressure and temperature monitoring. Its durable construction and corrosion-resistant materials ensure longevity. Hospitals rely on vertical autoclaves for their crucial role in infection control, maintaining aseptic conditions, and ensuring the safety and health of patients and healthcare professionals, making it a vital asset in hospital settings.
The Carbon Dioxide Incubator is a vital medical equipment utilized in hospitals for cell culture and research applications. It provides a controlled environment for cells, tissues, and cultures, mimicking physiological conditions. This incubator maintains precise temperature, humidity, and CO2 levels, ensuring optimal growth and viability of biological specimens. Equipped with advanced CO2 sensing and digital controls, it offers unparalleled accuracy and stability. The spacious interior accommodates various culture vessels. Its robust construction, contamination prevention features, and alarms guarantee aseptic conditions. Hospitals rely on CO2 incubators for critical tasks such as tissue culture, IVF, and microbiological research, making it an essential asset in healthcare and research.
COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of
The Oral Fluid Drug Screen Device for AMP/BAR/BUP/BZO/COC/COT/PCP/KET/MET/MOR/MTD/OXY/EDDP/PPX/THCparent/THC and metabolites is a rapid,oral fluid screeningtestthatcanbe performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in human oral fluid. 25 devices/box.
Indication: Qualitative detection of nucleic acid from SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19 by their healthcare provider. Emergency use of this test is limited to authorized laboratories. Authorized Laboratories: Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, to perform high complexity tests. This letter is in response to your1 request that the Food and Drug Administration (FDA) issue an Emergency Use Authorization (EUA) for emergency use of your product,2 pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. 360bbb-3). On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act. Having concluded that the criteria for issuance of this authorization under Section 564(c) of the Act are met, I am authorizing the emergency use of your product, described in the Scope of Authorization of this letter (Section II), subject to the terms of this authorization. I. Criteria for Issuance of Authorization I have concluded that the emergency use of your product meets the criteria for issuance of an authorization under Section 564(c) of the Act, because I have concluded that: 1. The SARS-CoV-2 can cause a serious or life-threatening disease or condition, including severe respiratory illness, to humans infected by this virus; 2. Based on the totality of scientific evidence available to FDA, it is reasonable to believe that your product may be effective in diagnosing COVID-19, and that the known and potential benefits of your product when used for diagnosing COVID-19, outweigh the known and potential risks of your product; and, 3. There is no adequate, approved, and available alternative to the emergency use of your product. 4 II. Scope of Authorization I have concluded, pursuant to Section 564(d)(1) of the Act, that the scope of this authorization is limited to the indication above.
The COVID-19 RT-PCR Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C. 263a, to perform high complexity tests. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infective status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial co-infection with other viruses. Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The COVID-19 RT-PCR Detection Kit is intended for use by qualified trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures. The COVID-19 RT-PCR Detection Kit is only for use under the Food and Drug Administration's Emergency Use Authorization. PRINCIPLE OF DETECTION This product is a fluorescent probe-based Taqman RT-PCR assay system. Firstly, the RNA of SARS-CoV-2 will be reverse transcribed into cDNA by reverse transcriptase, and then PCR amplification will be performed with cDNA as template. During amplification of the template, the TaqMan probe will be degraded due to the 5'-3 polymerase activity and exonuclease activity of Taq DNA polymerase, then the separation of fluorescent reporter and quencher enables the fluorescent signal to be detected by instrument. The ORF1ab gene of SARS-CoV-2 will be detected qualitatively by FAM channel, the N gene of SARS-CoV-2 will be detected qualitatively by JOE channel, the E gene of SARS-CoV-2 will be detected qualitatively by ROX channel, and the internal reference will be detected by CY5 channel. dUTP and UNG enzyme are used in the kit to prevent contamination of the amplified products. Internal reference is used in the kit for quality control starting from sample collection
The GENEDIA W COVID-19 Ag is an in vitro diagnostic single-use test and qualitative immunoassay to detect SARS-CoV-2 antigen in nasopharyngeal swab and sputum specimen from human. This assay is designed for professional personnel in laboratory and at point-of-care as an aid in screening patients suspected of being infected and asymptomatic patients. Allow wider testing with fast test time (10 minutes) Clinically proven data of asymptomatic patients available Separately packed extraction solution to minimize the possibility of contamination No additional instruments required Package Unit : 20 Tests/Kit Expiration Date : 24 Months (while sealed in the original aluminum foil pouch) GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva The price is negotiable according to the amount of your order and shipping term. No MOQ is required but we prefer 1 pallet with 9,600 tests. (20 tests/kit, 30 kits/carton, 16 cartons/pallet)
Product name: TORCH IgM Rapid Combo Test Device Format: Cassette Specimen: Whole blood/serum/plasma Test items: Toxo IgM, CMV IgM, Rubella IgM, HSV 1 IgM, and HSV 2 IgM Valid for: 24 months 2.Features -Customized sensitivity, printing color and packing -Accurate, quiet, stable, convenient -Latest production -Competitive quality and price -Easy payment and shipment
GENEDIA W COVID-19 Ag (Nasal swab) GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva
Rapid antigen test kits , viral transport media ( moh approved vtm kits), rna extraction kits , cr plates and machines. biochemistry analyser , biochemistry medias fda approved rapid test kits hiv , hcv , filter tips, laboratory consumables , agar plates , wolf air mask (the only device globally to be tested and effective 99.9 percent against covid 19).Export
FFP2 Cup-Shaped Valved Respirator Face Mask Easy to breathe with an exhalation valve CE certified by Apave Sudeurope (NB no. 0082) Tested and certified according to EN 149:2001+A1:2009 Class: FFP2 This valved respirator mask is certified and classified as FFP2 under EU standard EN 149:2001+A1:2009. EN 149:2001+A1:2009 - Respiratory protective devices - Filtering half masks to protect against particles. This European Standard specifies the minimum requirements for filtering half masks used as respiratory protective devices, specifically against particles, and the required laboratory and practical performance tests to assess masks' compliance. EN 149:2001+A1:2009 classified half masks into three types according to their filtering capacities: FFP1, FFP2 and FFP3. Respirators that meet the requirements of EN 149:2001+A1:2009 are designed to protect against solids, water-based aerosols, and oil-based aerosols. FFP2 masks have a minimum of 94% filtration percentage and maximum 8% leakage to the inside. They are mainly used in construction, agriculture, and by healthcare professionals against influenza viruses.
FFP3 Cup-Shaped Respirator Face Mask without Valve Valveless, avoid projecting contaminating particles into the air With adjustable head straps CE approved by UNIVERSAL (NB no. 2163) Tested and certified according to EN 149:2001+A1:2009 Class: FFP3 NR This valved respirator mask is certified and classified as FFP3 under EU standard EN 149:2001+A1:2009. EN 149:2001+A1:2009 - Respiratory protective devices - Filtering half masks to protect against particles. This European Standard specifies the minimum requirements for filtering half masks used as respiratory protective devices, specifically against particles, and the required laboratory and practical performance tests to assess masks' compliance. EN 149:2001+A1:2009 classified half masks into three types according to their filtering capacities: FFP1, FFP2 and FFP3. Respirators that meet the requirements of EN 149:2001+A1:2009 are designed to protect against solids, water-based aerosols, and oil-based aerosols. FFP3 masks have a minimum of 99% filtration percentage and maximum 2% leakage to the inside. They are mainly used in construction, agriculture, and by healthcare professionals against influenza viruses.
FFP3 Cup-Shaped Valved Respirator Face Mask Easy to breathe with an exhalation valve CE approved by UNIVERSAL (NB no. 2163) Tested and certified according to EN 149:2001+A1:2009 Class: FFP3 NR * Small orders are acceptable. This valved respirator mask is certified and classified as FFP3 under EU standard EN 149:2001+A1:2009. EN 149:2001+A1:2009 - Respiratory protective devices - Filtering half masks to protect against particles. This European Standard specifies the minimum requirements for filtering half masks used as respiratory protective devices, specifically against particles, and the required laboratory and practical performance tests to assess masks' compliance. EN 149:2001+A1:2009 classified half masks into three types according to their filtering capacities: FFP1, FFP2 and FFP3. Respirators that meet the requirements of EN 149:2001+A1:2009 are designed to protect against solids, water-based aerosols, and oil-based aerosols. FFP3 masks have a minimum of 99% filtration percentage and maximum 2% leakage to the inside. They are mainly used in construction, agriculture, and by healthcare professionals against influenza viruses.
SurgiDispo Nitrile Examination Gloves, Powder-Free, Thin Examination Gloves for Medical, Surgical, Chemotherapy, Cleaning, and Sanitation environments. Size: Small, Medium, Large, 100 Pcs Box, Packing: 10 /20/30 Boxes Case Salient Features Exceptional comfort and fit Tested for use with over 55 chemicals and approved for use with chemotherapy drugs* Better than industry standards, AQL delivers consistent, high-quality production
Lot of 20 Stryker Single Port Manifold REF 700-15 DISCLAIMER: The item is in its original condition and no alterations have been made to the item. The item has been properly stored and handled, following the manufacturers recommendations. The item comes with the accessories specifically mentioned in the description or shown in the pictures. This item is not a food or medical product that has expired. This item does not appear to be damaged or mishandled. To the best of seller’s knowledge the item has not been recalled. FDA REGULATION AND CERTIFICATION: · The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If so, do not bid on this item unless you are an authorized purchaser. If the item is subject to FDA regulation, I will verify your status as an authorized purchaser of this item before shipping of the item. · If you have questions about legal obligations regarding sales of medical devices, you should consult with the FDA's Center for Devices and Radiological Health:
Lot of 24 MiniHeart Hi-Flo Continuous Nebulizers Single patient use Within original factory packaging Single use only. Brand new in original unopened factory package. See pictures for more information. Not for human consumption. Not an implantable device. "The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. Do no purchase this item unless you are an authorized purchaser. If the item is subject to FDA regulation, I will verify your status as an authorized purchaser of this item before shipping of the item." DISCLAIMER: Regardless of the origin of the equipment, documentation provided or identification appearing upon the equipment, the equipment described and offered here is in no way certified for, recommended for, or offered for any specific use. The purchaser agrees that the seller shall not be held responsible or liable for any injuries or damages, whether incidental or consequential, associated in any way with the equipment. The purchaser, by purchasing this equipment, indicates their acknowledgment of, and agreement to the terms of this disclaimer.
Lot of 5 Arrow Injectable Multi-Lumen CVC Kit REF CDC-45703-XP1A EXP. 2012-11 Single use only. Brand new in original unopened factory package. See pictures for more information. Not for human consumption. Not an implantable device. "The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. Do no purchase this item unless you are an authorized purchaser. If the item is subject to FDA regulation, I will verify your status as an authorized purchaser of this item before shipping of the item." DISCLAIMER: Regardless of the origin of the equipment, documentation provided or identification appearing upon the equipment, the equipment described and offered here is in no way certified for, recommended for, or offered for any specific use. The purchaser agrees that the seller shall not be held responsible or liable for any injuries or damages, whether incidental or consequential, associated in any way with the equipment. The purchaser, by purchasing this equipment, indicates their acknowledgment of, and agreement to the terms of this disclaimer.
